May 22 (Reuters) - Sirtex Medical Ltd (SRX) :
- ASX ALERT-SIRTEX RECEIVES BINDING OFFER FROM CDH-SRX.AX
- HAS RECEIVED OFFER CAPABLE OF ACCEPTANCE FROM CDH GENETECH LIMITED FOR ACQUISITION OF ALL OF SHARES IN SIRTEX
- BOARD OF SIRTEX IS CONSIDERING RELATIVE MERITS AND RISKS OF CDH PROPOSAL AND VARIAN SCHEME
- WORLDWIDE DOSE SALES FOR PERIOD 1 JANUARY TO 30 APRIL 2018 WERE 3,755, DOWN 10.6% VERSUS PCP
- NOW ANTICIPATES THAT FY18 UNDERLYING EBITDA WILL BE AT LOWER END OF $75-85 MILLION GUIDANCE PREVIOUSLY ISSUED
- DIRECTORS OF SIRTEX CONTINUE TO UNANIMOUSLY SUPPORT AND RECOMMEND VARIAN SCHEME
- SECOND HALF DOSE SALES ARE EXPECTED TO BE RELATIVELY FLAT VERSUS FIRST HALF
May 22 (Reuters) - Sirtex Medical Ltd (SRX) : ASX ALERT-SIRTEX...
Add to My Watchlist
What is My Watchlist?